journal article·2026-03Open access

Precise Construction of an Antimicrobial Peptide Targeting Bacterial Cell Membranes Derived From Natural Peptides

Jiaqi Huang, Bohao Liu, Xingzhuo Zhu, Deqian Qiao, Sizhe Chen, Xiaoyan Zeng, Qingqing Yang, Zihuan Wei, Yinjuan Huang, Jizhao Wang, Guangjian Zhang, Qiuyu Gong

Advanced Science· Volume 13· Issue 17

Abstract

ABSTRACT Antimicrobial peptides (AMPs) are promising alternatives to overcome antimicrobial resistance (AMR). However, precise construction of an AMP targeting bacterial cell membranes derived from natural peptides remains a great challenges. Although the artificial intelligence (AI) algorithm‐assisted screening method has achieved unprecedented successes, it's difficult to predict the targets of AMPs obtained from this method. To address this, an AMP ( P 3‐3R‐8I ) based on several natural peptides derived from insect cuticle was constructed precisely via amino acid mutation. The mutated amino acids Arginine (R) and Isoleucine (I) are expected to target the bacterial cell membranes. Surprisingly, P 3‐3R‐8I exhibits super antibacterial capability against two representative bacteria: methicillin‐resistant Staphylococcus aureus (MRSA) and Escherichia coli ( E. coli ), which could be attributed to the ability to quickly penetrate bacterial cell membranes and then to bind to bacterial DNA of P 3‐3R‐8I , resulting in the suppression of DNA replication. In rats’ model, the MRSA‐infected wound could be alleviated by P 3‐3R‐8I obviously, as well as lung and spleen infections in MRSA‐induced systemic sepsis. Our findings provide a prospect for the precise construction of AMPs targeting bacterial cell membranes as well as a means of overcoming AMR, offering a strategy for drug‐resistant bacteria‐induced tissue repair.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Antimicrobial Peptides and Activities · Antimicrobial agents and applications · Microbial Natural Products and Biosynthesis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Thoracic Surgery The First Affiliated Hospital of Xi'an Jiaotong University Xi'an P. R. China

Key Laboratory of Enhanced Recovery After Surgery of Integrated Chinese and Western Medicine Administration of Traditional Chinese Medicine of Shaanxi Province The First Affiliated Hospital of Xi'an Jiaotong University Xi'an P. R. China

Microbiota I‐Center Chinese University of Hong Kong Hong Kong P. R. China

Department of Laboratory Medicine The First Affiliated Hospital of Xi'an Jiaotong University Xi'an P. R. China

State Key Laboratory of Porous Metal Materials Shaanxi International Research Center for Soft Matter School of Materials Science and Engineering Xi'an Jiaotong University Xi'an P. R. China

Key Laboratory of Optic‐Electric Sensing and Analytical Chemistry For Life Science Ministry of Education Qingdao University of Science and Technology Qingdao P. R. China

References (49)

Show source-provided references
1. 10.1016/S0140-6736(24)01867-110.1016/S0140-6736(24)01867-1 ↗
2. 10.3390/healthcare1113194610.3390/healthcare11131946 ↗
3. 10.1016/j.glmedi.2024.10008110.1016/j.glmedi.2024.100081 ↗
4. 10.1002/advs.20240527210.1002/advs.202405272 ↗
5. 10.1186/s12951‐022‐01573‐910.1186/s12951‐022‐01573‐9 ↗
6. 10.1002/jps.2369110.1002/jps.23691 ↗
7. 10.3389/fphar.2018.0079010.3389/fphar.2018.00790 ↗
8. 10.1186/s40168-024-01985-910.1186/s40168-024-01985-9 ↗
9. 10.1016/j.drup.2023.10095410.1016/j.drup.2023.100954 ↗
10. 10.1080/1040841X.2023.218621510.1080/1040841X.2023.2186215 ↗
11. Antimicrobial Peptides: A Promising Alternative to Conventional Antimicrobials for Combating Polymicrobial Biofilms
12. 10.1038/s41551‐021‐00689‐x10.1038/s41551‐021‐00689‐x ↗
13. 10.1038/s44222-024-00152-x10.1038/s44222-024-00152-x ↗
14. 10.1016/j.cell.2024.05.01310.1016/j.cell.2024.05.013 ↗
15. 10.1038/s41551‐024‐01201‐x10.1038/s41551‐024‐01201‐x ↗
16. 10.1038/s41551‐022‐00991‐210.1038/s41551‐022‐00991‐2 ↗
17. 10.1021/acs.jcim.3c0188110.1021/acs.jcim.3c01881 ↗
18. 10.1038/s41563-025-02164-310.1038/s41563-025-02164-3 ↗
19. 10.15252/msb.20211030510.15252/msb.202110305 ↗
20. 10.1038/s42003‐022‐04164‐410.1038/s42003‐022‐04164‐4 ↗
21. 10.1186/s12915‐022‐01304‐410.1186/s12915‐022‐01304‐4 ↗
22. 10.1021/acsnano.3c0713110.1021/acsnano.3c07131 ↗
23. 10.1021/acs.biomac.2c0026110.1021/acs.biomac.2c00261 ↗
24. 10.1016/j.actbio.2022.09.02810.1016/j.actbio.2022.09.028 ↗
25. 10.1021/acs.jcim.1c0083810.1021/acs.jcim.1c00838 ↗
26. 10.1016/j.jinorgbio.2024.11276110.1016/j.jinorgbio.2024.112761 ↗
27. 10.1186/s40779-021-00343-210.1186/s40779-021-00343-2 ↗
28. 10.1002/celc.20240015310.1002/celc.202400153 ↗
29. 10.3390/biom801000410.3390/biom8010004 ↗
30. 10.1021/acsabm.4c0108410.1021/acsabm.4c01084 ↗
31. The Antimicrobial Peptides and Their Potential Clinical Applications
32. 10.1021/acs.jctc.4c0020410.1021/acs.jctc.4c00204 ↗
33. 10.1021/ja809324710.1021/ja8093247 ↗
34. 10.1038/s41467‐025‐65449‐w10.1038/s41467‐025‐65449‐w ↗
35. 10.1021/acs.chemrestox.0c0028510.1021/acs.chemrestox.0c00285 ↗
36. 10.1021/acsnano.4c1885810.1021/acsnano.4c18858 ↗
37. 10.1021/acs.jmedchem.2c0202110.1021/acs.jmedchem.2c02021 ↗
38. 10.3389/fvets.2022.101072810.3389/fvets.2022.1010728 ↗
39. 10.3390/ijms2304205210.3390/ijms23042052 ↗
40. 10.1111/1440‐1681.1306610.1111/1440‐1681.13066 ↗
41. 10.3390/bioengineering805006310.3390/bioengineering8050063 ↗
42. 10.1684/ecn.2009.015510.1684/ecn.2009.0155 ↗
43. 10.1093/brain/awh48910.1093/brain/awh489 ↗
44. 10.1002/advs.20220690010.1002/advs.202206900 ↗
45. 10.3389/fonc.2020.0156210.3389/fonc.2020.01562 ↗
46. 10.1038/sj.jid.570058810.1038/sj.jid.5700588 ↗
47. 10.1038/ng0794‐38310.1038/ng0794‐383 ↗
48. 10.1016/j.adoms.2022.10025310.1016/j.adoms.2022.100253 ↗
49. 10.1016/j.bbrc.2008.11.01110.1016/j.bbrc.2008.11.011 ↗